v3.26.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid- In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 413,640 $ 8 $ 1,308,290 $ 764 $ (895,422)
Beginning balance (in shares) at Dec. 31, 2024   78,229,000      
Share-based compensation expense 7,842   7,842    
Issuance of common stock under equity plans 143   143    
Issuance of common stock under equity plans (in shares)   375,000      
Exercise of pre-funded warrants (shares)   2,174,000      
Other comprehensive income (loss) 210     210  
Net loss (57,429)       (57,429)
Ending balance at Mar. 31, 2025 364,406 $ 8 1,316,275 974 (952,851)
Ending balance (in shares) at Mar. 31, 2025   80,778,000      
Beginning balance at Dec. 31, 2024 413,640 $ 8 1,308,290 764 (895,422)
Beginning balance (in shares) at Dec. 31, 2024   78,229,000      
Net loss (123,551)        
Ending balance at Jun. 30, 2025 305,486 $ 9 1,323,739 711 (1,018,973)
Ending balance (in shares) at Jun. 30, 2025   86,797,000      
Beginning balance at Mar. 31, 2025 364,406 $ 8 1,316,275 974 (952,851)
Beginning balance (in shares) at Mar. 31, 2025   80,778,000      
Share-based compensation expense 6,949   6,949    
Issuance of common stock under equity plans 515   515    
Issuance of common stock under equity plans (in shares)   101,000      
Exercise of pre-funded warrants 1 $ 1      
Exercise of warrants (in shares)   5,918,000      
Other comprehensive income (loss) (263)     (263)  
Net loss (66,122)       (66,122)
Ending balance at Jun. 30, 2025 305,486 $ 9 1,323,739 711 (1,018,973)
Ending balance (in shares) at Jun. 30, 2025   86,797,000      
Beginning balance at Dec. 31, 2025 174,135 $ 9 1,347,190 1,024 (1,174,088)
Beginning balance (in shares) at Dec. 31, 2025   87,855,000      
Share-based compensation expense 8,416   8,416    
Issuance of common stock under equity plans 69   69    
Issuance of common stock under equity plans (in shares)   470,000      
Exercise of pre-funded warrants (shares)   417,000      
Exercise of warrants (in shares)   21      
Other comprehensive income (loss) (1,404)     (1,404)  
Net loss (73,333)       (73,333)
Ending balance at Mar. 31, 2026 107,883 $ 9 1,355,675 (380) (1,247,421)
Ending balance (in shares) at Mar. 31, 2026   88,763,000      
Beginning balance at Dec. 31, 2025 174,135 $ 9 1,347,190 1,024 (1,174,088)
Beginning balance (in shares) at Dec. 31, 2025   87,855,000      
Net loss (141,660)        
Ending balance at Jun. 30, 2026 48,431 $ 9 1,365,383 (1,213) (1,315,748)
Ending balance (in shares) at Jun. 30, 2026   88,954,000      
Beginning balance at Mar. 31, 2026 107,883 $ 9 1,355,675 (380) (1,247,421)
Beginning balance (in shares) at Mar. 31, 2026   88,763,000      
Share-based compensation expense 8,209   8,209    
Issuance of common stock under equity plans 1,499   1,499    
Issuance of common stock under equity plans (in shares)   191,000      
Other comprehensive income (loss) (833)     (833)  
Net loss (68,327)       (68,327)
Ending balance at Jun. 30, 2026 $ 48,431 $ 9 $ 1,365,383 $ (1,213) $ (1,315,748)
Ending balance (in shares) at Jun. 30, 2026   88,954,000